Long-term safety and efficacy of roflumilast cream 0.3% in adult patients with chronic plaque psoriasis: results from a 52-week, phase 2b open-label study
Authors: Linda Stein Gold, Melinda J Gooderham, Kim A Papp, Laura K Ferris, Mark Lebwohl, David N Adam, Javier Alonso-Llamazares, H Chih-ho Hong, Steven E Kempers, Leon H Kircik, Wei Jing Loo, Walter K Nahm, Daniel Stewart, Matthew Zirwas, Patrick Burnett, Robert C Higham, Lynn Navale, David R Berk